Business Standard

Mangalam Drugs and Organics standalone net profit declines 57.43% in the March 2021 quarter

Image

Capital Market

Sales rise 3.07% to Rs 90.79 crore

Net profit of Mangalam Drugs and Organics declined 57.43% to Rs 2.15 crore in the quarter ended March 2021 as against Rs 5.05 crore during the previous quarter ended March 2020. Sales rose 3.07% to Rs 90.79 crore in the quarter ended March 2021 as against Rs 88.09 crore during the previous quarter ended March 2020.

For the full year,net profit rose 239.03% to Rs 27.97 crore in the year ended March 2021 as against Rs 8.25 crore during the previous year ended March 2020. Sales rose 34.63% to Rs 380.14 crore in the year ended March 2021 as against Rs 282.35 crore during the previous year ended March 2020.

 
ParticularsQuarter EndedYear EndedMar. 2021Mar. 2020% Var.Mar. 2021Mar. 2020% Var.Sales90.7988.09 3 380.14282.35 35 OPM %10.438.13 -14.028.39 - PBDT9.365.15 82 48.7014.47 237 PBT6.843.05 124 39.526.25 532 NP2.155.05 -57 27.978.25 239

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: May 20 2021 | 5:52 PM IST

Explore News